• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

DiaMonTech raises $5M for laser-based blood glucose detection system

February 18, 2022 By Sean Whooley

DiaMonTech
[Image from DiaMonTech’s website]
DiaMonTech announced today that it raised $5 million to bring its total funding to more than $20 million to date.

Berlin, Germany-based DiaMonTech develops a patented, mid-infrared technology platform designed to enable non-invasive blood glucose measurement using pain-free laser-based detection. The platform has ease of use comparable to the fingerprint sensor on a smartphone, according to the company.

The company aims for the platform to allow for managing blood glucose levels without finger pricking, needles and test strips.

According to a news release, the company expects to use the new funds to accelerate its product development and enable its international expansion to the U.S. with growing interest in its first portable product, the “D-Pocket.”

Samsung Ventures, along with a global medtech company, joined as strategic partners, which DiaMonTech said reaffirms its ambition to make waves in non-invasive diabetes management.

“We are delighted to welcome Samsung Ventures as strategic partner to this financing round along with Unorthodox Ventures, Golden Light and the existing shareholders around IBB Ventures,” DiaMonTech CEO Thorsten Lubinski said in the release.”Our investors have backed a wave of revolutionary tech companies. Their commitment to DiaMonTech is a vote of confidence in our team and technology.”

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Patient Monitoring Tagged With: DiaMonTech

IN CASE YOU MISSED IT

  • Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
  • Verily’s Onduo, Sword Health collaborate on virtual diabetes care
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS